Senores Pharmaceuticals Ltd.

NSE: SENORES | BSE: 544319

Download real time

523.85 3.70 (0.71%)

110.4K NSE+BSE Volume

NSE 23 Jun, 2025 3:31 PM (IST)

2,412.5

Market Cap

Above industry Median

-

Beta 1Year

Senores Pharmaceuticals Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for SENORES, BSE:544319 Senores Pharmaceuticals Ltd.

Search Inside the pdf :

Senores Pharmaceuticals Ltd.

19 Dec 2024

523.85

0.71%

Senores Pharmaceuticals Ltd IPO Note

buy

IPO Subscribe: Senores Pharmaceuticals Ltd.

SBI Securities

Number of FII/FPI investors decreased from 51 to 41 in Mar 2025 qtr

Senores Pharmaceuticals Ltd.

19 Dec 2024

523.85

0.71%

IPO Note

buy

IPO Note: Senores Pharmaceuticals Ltd.

KRChoksey

Senores Pharmaceuticals focuses on generic drugs and specialty medications across various therapeutic areas, including cardiovascular, diabetes, gastroenterology, and critical care injectables. The company manufactures products at its FDA-approved facilities, with a significant presence in regulated markets like the US, UK, and Canada.

Number of FII/FPI investors decreased from 51 to 41 in Mar 2025 qtr

RESEARCH REPORTS

IPO Note SEE REPORTS >